Ligand-dependent transcriptional heterogeneity in cell cycle gene expression delays G1/S entry.
It is shown that EGF and HRG induce different modes of G1/S progression in ErbB2-amplified BT474 breast cancer cells, revealing that ligand-specific ErbB signaling controls not only the timing of cell-cycle entry but also the transcriptional architecture that governs proliferative fate decisions.